Related Experiment Video
Updated: Jan 24, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study
Rabia Agca1,2, Luuk H G A Hopman3,4, Koen J C Laan3,4
1From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center; Department of Cardiology, and Department of Internal Medicine, and Department of Epidemiology and Biostatistics, and Department of General Practice, and EMGO Institute for Health and Care Research, Amsterdam UMC, VU University Medical Center; Amsterdam UMC, Academic Medical Center, Department of Cardiology; Department of Internal Medicine, and the Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands. r_agca@hotmail.com.
Insights
Patients with rheumatoid arthritis (RA) face more than double the risk of cardiovascular disease (CVD) events compared to the general population. This elevated CVD risk in RA persists even after accounting for traditional risk factors, highlighting inflammation
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Cardiovascular disease (CVD) risk is significantly elevated in patients with rheumatoid arthritis (RA).
- Long-term follow-up studies investigating this increased CVD risk in RA are limited.
Purpose of the Study:
- To prospectively investigate cardiovascular disease (CVD) incidence and risk factors in patients with longstanding rheumatoid arthritis (RA).
- To compare CVD risk in RA patients against a reference cohort, including individuals with type 2 diabetes (DM).
Main Methods:
- The CARRÉ study is a prospective cohort study involving 353 patients with longstanding RA.
- Cardiovascular endpoints were assessed over 15 years and compared to a reference cohort of 2540 individuals.
- Statistical analysis included age- and sex-adjusted hazard ratios (HR) and adjustments for traditional CV risk factors.
Main Results:
- The incidence rate of CV events in RA patients was 3.20 per 100 person-years, more than double the reference cohort's rate (1.36 per 100 person-years).
- RA patients had a 2.07-fold increased risk of CV events compared to controls, which remained significant (HR 1.82) after adjusting for CV risk factors.
- Patients with both RA and type 2 diabetes (DM) or insulin resistance exhibited the highest CVD risk.
Conclusions:
- Established rheumatoid arthritis (RA) is associated with a more than twofold increased incidence of cardiovascular events compared to the general population.
- The heightened CVD risk in RA patients exceeds that seen in type 2 diabetes (DM) and is independent of traditional cardiovascular risk factors.
- Systemic inflammation in RA appears to be a significant, independent contributor to cardiovascular risk.
Objective:
Cardiovascular (CV) disease (CVD) risk is increased in rheumatoid arthritis (RA). However, longterm followup studies investigating this risk are scarce.
Methods:
The CARRÉ (CARdiovascular research and RhEumatoid arthritis) study is a prospective cohort study investigating CVD and its risk factors in 353 patients with longstanding RA. CV endpoints were assessed at baseline and 3, 10, and 15 years after the start of the study and are compared to a reference cohort (n = 2540), including a large number of patients with type 2 diabetes (DM).
Results:
Ninety-five patients with RA developed a CV event over 2973 person-years, resulting in an incidence rate of 3.20 per 100 person-years. Two hundred fifty-seven CV events were reported in the reference cohort during 18,874 person-years, resulting in an incidence rate of 1.36 per 100 person-years. Age- and sex-adjusted HR for CV events were increased for RA (HR 2.07, 95% CI 1.57-2.72, p < 0.01) and DM (HR 1.51, 95% CI 1.02-2.22, p = 0.04) compared to the nondiabetic participants. HR was still increased in RA (HR 1.82, 95% CI 1.32-2.50, p < 0.01) after additional adjustment for CV risk factors. Patients with both RA and DM or insulin resistance had the highest HR for developing CVD (2.21, 95% CI 1.01-4.80, p = 0.046 and 2.67, 95% CI 1.30-5.46, p < 0.01, respectively).
Conclusion:
The incidence rate of CV events in established RA was more than double that of the general population. Patients with RA have an even higher risk of CVD than patients with DM. This risk remained after adjustment for traditional CV risk factors, suggesting that systemic inflammation is an independent contributor to CV risk.
More Related Videos
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Longitudinal Studies
Longitudinal Research
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Imaging Studies for Cardiovascular System V: CT